Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Battery module
Fuel cell module, manufacturing method thereof and unit containing several of the latter
Transaction finance processing system and approach
Tray for microwave cooking and folding of a food product
Method of forming a semiconductor package
Diaminocyclohexane compounds and uses thereof
Ni-, Co-, and Mn- multi-element doped positive electrode material for lithium battery and its preparation method
  Randomly Featured Patents
Method and apparatus for calibrating transducer/amplifier systems
Sensor element for fluorescence-optical measurement
Flare minimization in split V-roof mirror collector
Communicating via an in-die interconnect
Power-based hardware diversity
Container yoke
Structural panel and method of manufacture
Modular structures having hinge and mating pin fastening means
Topical anesthetic